Pedro Rodriguez Cutillas
Pedro Rodriguez Cutillas
Barts Cancer Institute, Queen Mary University of London
Verified email at - Homepage
Cited by
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration
M Graupera, J Guillermet-Guibert, LC Foukas, LK Phng, RJ Cain, ...
Nature 453 (7195), 662-666, 2008
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
N Herranz, S Gallage, M Mellone, T Wuestefeld, S Klotz, CJ Hanley, ...
Nature cell biology 17 (9), 1205-1217, 2015
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
M Sciacovelli, E Gonçalves, TI Johnson, VR Zecchini, ASH da Costa, ...
Nature 537 (7621), 544-547, 2016
Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers
B Geering, PR Cutillas, G Nock, SI Gharbi, B Vanhaesebroeck
Proceedings of the National Academy of Sciences 104 (19), 7809-7814, 2007
Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells
P Casado, JC Rodriguez-Prados, SC Cosulich, S Guichard, ...
Sci. Signal. 6 (268), rs6-rs6, 2013
The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells
PR Cutillas, RJ Chalkley, KC Hansen, R Cramer, AGW Norden, ...
American Journal of Physiology-Renal Physiology 287 (3), F353-F364, 2004
Quantitative profile of five murine core proteomes using label-free functional proteomics
PR Cutillas, B Vanhaesebroeck
Molecular & Cellular Proteomics 6 (9), 1560-1573, 2007
Current challenges in software solutions for mass spectrometry-based quantitative proteomics
S Cappadona, PR Baker, PR Cutillas, AJR Heck, B van Breukelen
Amino acids 43 (3), 1087-1108, 2012
Detection and analysis of urinary peptides by on-line liquid chromatography and mass spectrometry: application to patients with renal Fanconi syndrome
PR Cutillas, AGW Norden, R Cramer, AL Burlingame, RJ Unwin
Clinical Science 104 (5), 483-490, 2003
Advances in phosphopeptide enrichment techniques for phosphoproteomics
L Beltran, PR Cutillas
Amino acids 43 (3), 1009-1024, 2012
Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction
LF Quintana, JM Campistol, MP Alcolea, E Bañon-Maneus, ...
Molecular & Cellular Proteomics 8 (7), 1658-1673, 2009
Characterization of a TiO2 enrichment method for label-free quantitative phosphoproteomics
A Montoya, L Beltran, P Casado, JC Rodríguez-Prados, PR Cutillas
Methods 54 (4), 370-378, 2011
Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers
OMT Pearce, RM Delaine-Smith, E Maniati, S Nichols, J Wang, S Böhm, ...
Cancer discovery 8 (3), 304-319, 2018
Quantitative amino acid and proteomic analysis: very low excretion of polypeptides> 750 Da in normal urine
AGW Norden, P Sharratt, PR Cutillas, R Cramer, SC Gardner, RJ Unwin
Kidney international 66 (5), 1994-2003, 2004
Quantification of gel-separated proteins and their phosphorylation sites by LC-MS using unlabeled internal standards: analysis of phosphoprotein dynamics in a B cell lymphoma …
PR Cutillas, B Geering, MD Waterfield, B Vanhaesebroeck
Molecular & Cellular Proteomics 4 (8), 1038-1051, 2005
Characterization of the extracellular matrix of normal and diseased tissues using proteomics
A Naba, OMT Pearce, A Del Rosario, D Ma, H Ding, V Rajeeve, ...
Journal of proteome research 16 (8), 3083-3091, 2017
Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits?
B Geering, PR Cutillas, B Vanhaesebroeck
Biochemical Society Transactions 35 (2), 199-203, 2007
Proteomic analysis of plasma membrane vesicles isolated from the rat renal cortex
PR Cutillas, J Biber, J Marks, R Jacob, B Stieger, R Cramer, M Waterfield, ...
Proteomics 5 (1), 101-112, 2005
Phosphoproteomic analysis of leukemia cells under basal and drug-treated conditions identifies markers of kinase pathway activation and mechanisms of resistance
MP Alcolea, P Casado, JC Rodríguez-Prados, B Vanhaesebroeck, ...
Molecular & Cellular Proteomics 11 (8), 453-466, 2012
The system can't perform the operation now. Try again later.
Articles 1–20